This discussion has become a moot point across sectors in India Inc., as promoters are looking at the next generation to not ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.

Mirum Pharmaceuticals (MIRM) announced that its partner, Takeda (TAK), has received approval by the Japanese Ministry of Health, Labour, and ...

Rigel Pharmaceuticals (RIGL) announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and ...

GIFT Nifty was trading lower at 23,502, which indicates a negative start for domestic indices. Here are the top stocks to ...

As Anant Ambani’s wedding anniversary approaches, we take a look at the staggering wealth of Mukesh and Nita Ambani’s in-laws ...

From the Piramals and Mehtas to the Mariwalas and Mittals, the Ambanis are connected to large business empires of India.

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

Nandini Piramal says the CDMO business, which contributed 58% of revenues in FY24, aspires to grow as a $1.2 billion business with a 25% EBITDA margin by 2030 ...